Furthermore, postnatal inactivation of
htt in brain and testis produces a progressive behavioral phenotype, neurodegeneration, and reduced survival suggesting that htt is required for neuronal function and survival (Dragatsis et al., 2000).
We present here the first comprehensive behavioral analysis of the effects of a conditional knock - down (starting at 4.5 weeks of age) of WT endogenous
htt in adult mice in the absence of any potential mutant gain - of - function.
More research is needed to further explore the role of WT
htt in the adult as well as to determine what level of adult WT htt knockdown will be permissible while attempting to reduce the mutant Htt protein.
In order to better understand the liabilities associated with reducing normal
htt in adult mice, we evaluated the effects of a robust knock down of WT htt both in CNS and periphery in a conditional htt knock - down (KD) model induced by doxycycline.
Furthermore, postnatal inactivation of
htt in brain and testes also produces a progressive behavioral phenotype in mice along with neurodegeneration and reduced survival.
Reduction of endogenous striatal htt using siRNA in rats expressing Htt171 - 82Q had no further detrimental effect on neuronal survival nor htt inclusion load indicating that partial inactivation of endogenous WT
htt in the adult striatum (~ 50 %) had no major impact on the course of HD pathology (Drouet et al, 2009).
Not exact matches
HTT, which lays claim to the brand name «hyperloop» — a futuristic transport system that essentially involves sucking people through a vacuum tube at high speed — says it is «building the first commercial line
in Abu Dhabi.»
Hyperloop Transportation Technologies (
HTT) and Virgin Hyperloop One are duking it out
in the Middle East.
Los Angeles - based
HTT was founded
in 2013, the same year SpaceX founder Elon Musk introduced the nearly 800 - mile - per - hour transportation tube concept.
In a statement, HTT chief executive officer Dirk Ahlborn said that connecting the three cities with a Hyperloop system would «incentivize collaboration and innovation within Slovakia and throughout Europe,» adding that Slovakia has been a technological leader in the automotive and energy industrie
In a statement,
HTT chief executive officer Dirk Ahlborn said that connecting the three cities with a Hyperloop system would «incentivize collaboration and innovation within Slovakia and throughout Europe,» adding that Slovakia has been a technological leader
in the automotive and energy industrie
in the automotive and energy industries.
Next week, Musk's SpaceX is hosting a capsule design competition where high school and college students will present designs
in hopes of winning a $ 50,000 prize and the opportunity to work with
HTT competitor Hyperloop Technologies.
In the same article, Ahlborn expressed his own frustration that Hyperloop Tech, founded after
HTT, had selected such a similar company name.
Lloyd and BamBrogan also took issue with recent media reports saying that
HTT was «breaking ground» on a test track
in the planned Quay Valley development
in California.
Hyperloop Tech's rhetoric may even show, albeit
in a backhanded way, that it takes
HTT seriously as a long - term competitor.
Last fall, Hyperloop Transportation Technologies (
HTT), a competitor with a similar name, said it would build a five - mile test track
in central California.
Earlier this March,
HTT said it reached an agreement with Slovakia for a possible Hyperloop system to be built
in that country.
Musk, whose interests span electric cars, solar power and space rockets, isn't interested
in commercially developing the idea, so a number of companies, including
HTT, have pounced on it.
Citizens
in major Indian cities can see their life expectancy drop by two years amid environmental problems like air pollution, but
HTT can help resolve that, Gresta said.
HTT says it was the first to take on Musk's project
in 2013, and claims that the other two firms named their businesses after
HTT and used its logo.
In London, at an event called Transport To The Future, HTT's chief operation officer Bibop Gresta revealed that the $ 150 million five mile test track will be built in California's Quay Valle
In London, at an event called Transport To The Future,
HTT's chief operation officer Bibop Gresta revealed that the $ 150 million five mile test track will be built
in California's Quay Valle
in California's Quay Valley.
Concepts and renders from UCLA's Suprastudio
in collaboration with
HTT envision how it could pan out.
Since then, a research company called Hyperloop Transportation Technologies (
HTT)-- unaffiliated with Musk or any of his other companies and ventures — is right on track to making science - fiction legit science by building an actual test track for the technology
in California.
HTT plans to break ground on the project
in May 2016
in Quay Valley, California.
He remains close to members of both startups currently
in the lead to produce the first working Hyperloop — Hyperloop Transportation Technologies, or
HTT, and Hyperloop Technologies Inc., or HTI.
HTT bought land last year to begin initial construction on the Hyperloop
in Quay Valley — a proposed 75,000 resident, solar - powered concept city being built
in King's County, California that intends to use
HTT's test track as its main transportation system.
Built -
in AR screens could also help
HTT monetize
in other ways — with digital advertising to a captive audience for short bursts as passengers zip from city to city.
It's about $ 20 million per mile to build
HTT's version of the Hyperloop, according to Ahlborn — a fraction of the current cost of building high - speed rail
in the U.S.
If
HTT can prove that humans can be transported safely at such speeds, it could provoke others, including governments, to invest
in making Musk's plans a reality.
It halts an intermediate step
in the protein - making process by binding to genetic material known as RNA, blocking the issuing of final instructions for making the
Htt protein.
Next up: a larger trial
in hundreds of patients to see if lowering mutant
Htt protein slows progression of the disease, then a trial in healthy people who carry the mutant HTT gene to see if antisense treatments could prevent Huntington's altogeth
Htt protein slows progression of the disease, then a trial
in healthy people who carry the mutant
HTT gene to see if antisense treatments could prevent Huntington's altogeth
HTT gene to see if antisense treatments could prevent Huntington's altogether.
HD is caused by a mutation
in the human
HTT gene that results
in an abnormal expansion and misfolding of the corresponding huntingtin protein.
For example, scientists have not been able to resolve what function the
HTT gene serves normally, or how its mutation creates problems
in the brain.
Next we these tools to explore how mutations
in the
HTT protein impact on human cortical development and human neuronal and astroglial functions.
Finally we aim at identifying phenotype specific transcriptional targets of mutant
HTT (mut -
HTT) or
HTT loss of function
in relevant neuronal / glial populations.
We also investigated the effect of the adult - onset HD mutation on the role of
HTT during spindle orientation
in NSCs derived from HD - hESCs.
By combining SNP - targeting allele - specific silencing and gain - of - function approaches, we showed that a 46 - glutamine expansion
in human
HTT was sufficient for a dominant - negative effect on spindle orientation and changes
in the distribution within the spindle pole and the cell cortex of dynein, p150Glued and NuMA
in neural cells.
The RNAi - mediated silencing of both
HTT alleles
in neural stem cells derived from hESCs disrupted spindle orientation and led to the mislocalization of dynein, the p150Glued subunit of dynactin and the large nuclear mitotic apparatus (NuMA) protein.
Thus, neural derivatives of disease - specific human pluripotent stem cells constitute a relevant biological resource for exploring the impact of adult - onset HD mutations of the
HTT gene on the division of neural progenitors, with potential applications
in HD drug discovery targeting
HTT - dynein - p150Glued complex interactions.
HTT modulates mitotic spindle orientation and cell fate
in mouse cortical progenitors from the ventricular zone.
Molecular studies at PsychoGenics and other organizations have demonstrated that the excision of the neomycin resistance cassette results
in a modest but significant increase
in mutant
HTT mRNA levels, and a trend towards an increase
in soluble mHTT protein and extranuclear inclusions.
Expression of mutant
Htt appeared to alter the firing rate of STN neurons, as firing rates
in HET and HOM mice were lower than their WT littermate.
A 50 % reduction
in HDAC4 restored these and other electrophysiological changes
in both the R6 / 2 model, a transgenic over-expresser of Exon 1
HTT with an expanded polyglutamine repeat, and heterozygous Q175 knock -
in mice (Q175 + / --RRB-, which carry one normal and one mutant
HTT allele with an expanded repeat of ~ 190 polyglutamines,
in addition to reversing behavioral alterations
in R6 / 2 mice (Mielcarek et al, 2013; PLOS Biology,
in press).
While
Htt null KO mice do not survive to birth (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995), mice expressing a 50 % reduction of endogenous htt levels reveal cognitive and motor deficits (Nasir et al., 1995) and significant decreases in the number of neurons in globus pallidus and subthalamic nucleus (O'Kusky et al., 199
Htt null KO mice do not survive to birth (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995), mice expressing a 50 % reduction of endogenous
htt levels reveal cognitive and motor deficits (Nasir et al., 1995) and significant decreases in the number of neurons in globus pallidus and subthalamic nucleus (O'Kusky et al., 199
htt levels reveal cognitive and motor deficits (Nasir et al., 1995) and significant decreases
in the number of neurons
in globus pallidus and subthalamic nucleus (O'Kusky et al., 1999).
Reduction of
htt to 50 % endogenous levels produces viable mice with no overt phenotypes (Duyao et al., 1995; Zeitlin et al., 1995) however more detailed evaluation has revealed deficits
in cognition and motor behavior (Nasir et al., 1995) raising the possibility that lowered
htt starting
in development may have adverse effects
in the mouse.
Our data indicates that human
htt ameliorates the cognitive deficits observed
in the KD mice.
Knocking down the endogenous
htt protein resulted
in significant decrease
in body weight and hyperactive behavior
in the open field.
These data indicate that the disease mechanism may at least be partially driven by a loss - of - function
in the
htt protein.
Anticipation built
in 2013 when pharmaceutical giant Roche announced a partnership with Ionis to develop the ASO drug for HD, which they call * IONIS -
HTT Rx *.
These SNPs were chosen because their sequences tend to be different
in the normal and mutant
HTT gene: the ribbons at that point
in the good and bad kites» tails tend to be a different colour, distinguishable by the drone.
Farrar AM, Murphy CA, Paterson NE, Oakeshott S, He D, Alosio W, McConnell K, Menalled LB, Ramboz S, Park LC, Howland D, Brunner D. Cognitive deficits
in transgenic and knock -
in HTT mice parallel those
in Huntington's disease..